

Hyderabad based paediatrician Dr. Sivaranjani Santosh has brought new hope to seven children suffering from Allan-Herndon-Dudley Syndrome (AHDS), a rare genetic disorder. Through her dedicated efforts, she has helped make an extremely expensive medicine, Tiratricol, affordable for these children. With support from Access to Medicines India and an international foundation, the annual cost of the medicine, which was previously as high as ₹9 crore per child, has reportedly been reduced to approximately ₹2.5 lakh. This achievement is expected to provide significant relief to families struggling to afford treatment for this rare condition.
In another encouraging development, all seven children are set to receive a year's supply of Tiratricol completely free of cost on November 30, 2026. The initiative is expected to ease the financial burden on their families and ensure access to essential medication. Dr. Sivaranjani Santosh's efforts, along with the support of the organisations involved, have created fresh hope for children affected by rare genetic disorders. The initiative also highlights the importance of making life-changing medicines accessible and affordable to families in need.














Comments (0)
No comments yet
Be the first to comment!